Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01915056 · ClinicalTrials.gov registry record · NA
A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT01915056 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 80 participants.
The verdict
NCT01915056, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether information regarding GA and GA-driven interventions improves outcomes in older cancer patients receiving first-line or second-line chemotherapy by comparing rates of chemotherapy toxicity, hospitalizations, dose delays and early termination of treatment in patients with and without GA-driven interventions. The investigators will identify information that will be useful based on questionnaire responses and blood tests. These results will be used to better understand which recommendations and interventions will benefit older cancer patients. It is our hope that these tools, which are well-established at identifying areas of risk, will provide meaningful opportunities for intervention to promote your safety during cancer management. The investigators will be able to use this information to teach others on how to best care for adults aged 70 and older with cancer.
Interventions
- OTHER GA-driven Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01915056
The ClinicalTrials.gov registry entry for NCT01915056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GA-driven Intervention is the first listed.
NCT01915056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01915056 about?
NCT01915056 is a clinical study titled "A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy". The purpose of this study is to determine whether information regarding GA and GA-driven interventions improves outcomes in older cancer patients receiving first-line or second-line chemotherapy by comparing rates of chemotherapy toxicity, hospitalizations, dose delays and early termination of treat...
What is the current status of trial NCT01915056?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01915056?
The interventions under investigation include: GA-driven Intervention (OTHER).
Who is sponsoring clinical trial NCT01915056?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.